DK1212317T3 - Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser - Google Patents
Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelserInfo
- Publication number
- DK1212317T3 DK1212317T3 DK00943839T DK00943839T DK1212317T3 DK 1212317 T3 DK1212317 T3 DK 1212317T3 DK 00943839 T DK00943839 T DK 00943839T DK 00943839 T DK00943839 T DK 00943839T DK 1212317 T3 DK1212317 T3 DK 1212317T3
- Authority
- DK
- Denmark
- Prior art keywords
- osteoporosis
- treatment
- indole derivatives
- indole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9914371.1A GB9914371D0 (en) | 1999-06-18 | 1999-06-18 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1212317T3 true DK1212317T3 (da) | 2005-01-24 |
Family
ID=10855696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00943839T DK1212317T3 (da) | 1999-06-18 | 2000-06-16 | Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser |
Country Status (30)
Country | Link |
---|---|
US (2) | US6787550B1 (pt) |
EP (1) | EP1212317B1 (pt) |
JP (1) | JP2003503490A (pt) |
KR (1) | KR100701109B1 (pt) |
CN (1) | CN1179960C (pt) |
AR (1) | AR024390A1 (pt) |
AT (1) | ATE276245T1 (pt) |
AU (1) | AU768726B2 (pt) |
BR (1) | BR0011708A (pt) |
CA (1) | CA2376657A1 (pt) |
CO (1) | CO5200757A1 (pt) |
CZ (1) | CZ301697B6 (pt) |
DE (1) | DE60013859T2 (pt) |
DK (1) | DK1212317T3 (pt) |
ES (1) | ES2226870T3 (pt) |
GB (1) | GB9914371D0 (pt) |
GC (1) | GC0000341A (pt) |
HK (2) | HK1048468B (pt) |
HU (1) | HUP0202049A3 (pt) |
IL (2) | IL147012A0 (pt) |
MX (1) | MXPA01013277A (pt) |
MY (1) | MY129425A (pt) |
NO (1) | NO322313B1 (pt) |
NZ (1) | NZ516131A (pt) |
PL (1) | PL352964A1 (pt) |
PT (1) | PT1212317E (pt) |
TR (1) | TR200103683T2 (pt) |
TW (1) | TWI248440B (pt) |
WO (1) | WO2001002388A1 (pt) |
ZA (1) | ZA200200177B (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004073611A2 (en) | 2003-02-13 | 2004-09-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
MXPA06000538A (es) * | 2003-07-15 | 2006-03-30 | Smithkline Beecham Corp | Compuestos novedosos. |
ITMI20040875A1 (it) * | 2004-04-30 | 2004-07-30 | Ist Naz Stud Cura Dei Tumori | Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali |
EP1961757B1 (en) | 2004-09-17 | 2010-09-01 | IDENIX Pharmaceuticals, Inc. | Phosphoindoles as HIV inhibitors |
KR20070060156A (ko) * | 2004-10-04 | 2007-06-12 | 미리어드 제네틱스, 인크. | 알츠하이머병 치료용 화합물 |
US7833805B2 (en) * | 2004-10-21 | 2010-11-16 | University Of Cincinnati | Selectively permeable membranes on porous substrates |
EP1911744B1 (en) | 2005-07-20 | 2013-09-04 | Masanori Somei | Tryptophan derivative and use thereof |
ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
WO2007022269A2 (en) | 2005-08-15 | 2007-02-22 | Irm Llc | Compounds and compositions as tpo mimetics |
EP1779849A1 (en) * | 2005-10-28 | 2007-05-02 | Nikem Research S.R.L. | V-ATPase inhibitors for the treatment of septic shock |
EP1779848A1 (en) * | 2005-10-28 | 2007-05-02 | Nikem Research S.R.L. | V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases |
EP1976377A4 (en) | 2006-01-25 | 2010-06-23 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS |
EP1976510A4 (en) | 2006-01-25 | 2010-06-09 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER |
CN101378740A (zh) | 2006-02-02 | 2009-03-04 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
US8222261B2 (en) * | 2006-07-13 | 2012-07-17 | GlaxoSmithKline, LLC | Chemical compounds |
ES2488922T3 (es) | 2006-09-29 | 2014-09-01 | Idenix Pharmaceuticals, Inc. | Fosfoindoles enantiómeramente puros como inhibidores del HIV |
UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
ES2806691T3 (es) | 2009-02-16 | 2021-02-18 | Nogra Pharma Ltd | Compuestos de alquilamido y usos de los mismos |
US20110038852A1 (en) * | 2009-06-10 | 2011-02-17 | 3-V Biosciences, Inc. | Antivirals that target transporters, carriers, and ion channels |
CN103201268B (zh) * | 2010-09-08 | 2015-08-12 | 百时美施贵宝公司 | 作为广谱流感抗病毒药物的新型哌嗪类似物 |
WO2012045451A1 (en) | 2010-10-05 | 2012-04-12 | Ludwig-Maximilians-Universitaet Muenchen | Novel therapeutic treatment of progranulin-dependent diseases |
US20120142627A1 (en) * | 2010-12-06 | 2012-06-07 | Emory University | Monophosphate prodrugs of dapd and analogs thereof |
WO2013117744A2 (en) | 2012-02-09 | 2013-08-15 | Nogra Pharma Limited | Methods of treating fibrosis |
EP2844242A1 (en) | 2012-04-18 | 2015-03-11 | Nogra Pharma Limited | Methods of treating lactose intolerance |
BR112021015609A2 (pt) | 2019-02-08 | 2021-10-05 | Nogra Pharma Limited | Processo de fabricação de ácido 3-(4?-aminofenil)-2-metoxipropiônico, e análogos e intermediários do mesmo |
CN113024432A (zh) * | 2019-12-24 | 2021-06-25 | 上海科胜药物研发有限公司 | 一种氨磺必利药典杂质的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2124511C1 (ru) * | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
PL321263A1 (en) * | 1995-01-10 | 1997-11-24 | Smithkline Beecham Spa | Derivatives of indole useful in treating osteoporosis |
AU3620597A (en) * | 1996-07-09 | 1998-02-02 | Smithkline Beecham Laboratoires Pharmaceutiques | Indole derivatives for the treatment of osteoporosis |
PL191633B1 (pl) | 1997-12-24 | 2006-06-30 | Nikem Res Srl | Pochodne indolu i kompozycja farmaceutyczna zawierająca pochodną indolu |
-
1999
- 1999-06-18 GB GBGB9914371.1A patent/GB9914371D0/en not_active Ceased
-
2000
- 2000-06-16 WO PCT/EP2000/005672 patent/WO2001002388A1/en active IP Right Grant
- 2000-06-16 DK DK00943839T patent/DK1212317T3/da active
- 2000-06-16 CO CO00045017A patent/CO5200757A1/es not_active Application Discontinuation
- 2000-06-16 AR ARP000103010A patent/AR024390A1/es not_active Application Discontinuation
- 2000-06-16 US US10/018,443 patent/US6787550B1/en not_active Expired - Fee Related
- 2000-06-16 DE DE60013859T patent/DE60013859T2/de not_active Expired - Lifetime
- 2000-06-16 IL IL14701200A patent/IL147012A0/xx active IP Right Grant
- 2000-06-16 MX MXPA01013277A patent/MXPA01013277A/es active IP Right Grant
- 2000-06-16 CA CA002376657A patent/CA2376657A1/en not_active Abandoned
- 2000-06-16 NZ NZ516131A patent/NZ516131A/en unknown
- 2000-06-16 AT AT00943839T patent/ATE276245T1/de not_active IP Right Cessation
- 2000-06-16 KR KR1020017016180A patent/KR100701109B1/ko not_active IP Right Cessation
- 2000-06-16 BR BR0011708-0A patent/BR0011708A/pt not_active IP Right Cessation
- 2000-06-16 MY MYPI20002728A patent/MY129425A/en unknown
- 2000-06-16 PT PT00943839T patent/PT1212317E/pt unknown
- 2000-06-16 TR TR2001/03683T patent/TR200103683T2/xx unknown
- 2000-06-16 ES ES00943839T patent/ES2226870T3/es not_active Expired - Lifetime
- 2000-06-16 HU HU0202049A patent/HUP0202049A3/hu unknown
- 2000-06-16 CN CNB008115974A patent/CN1179960C/zh not_active Expired - Fee Related
- 2000-06-16 CZ CZ20014496A patent/CZ301697B6/cs not_active IP Right Cessation
- 2000-06-16 EP EP00943839A patent/EP1212317B1/en not_active Expired - Lifetime
- 2000-06-16 AU AU58165/00A patent/AU768726B2/en not_active Ceased
- 2000-06-16 PL PL00352964A patent/PL352964A1/xx not_active IP Right Cessation
- 2000-06-16 JP JP2001507825A patent/JP2003503490A/ja active Pending
- 2000-06-18 GC GCP2000726 patent/GC0000341A/en active
- 2000-07-06 TW TW089113348A patent/TWI248440B/zh not_active IP Right Cessation
-
2001
- 2001-12-10 IL IL147012A patent/IL147012A/en not_active IP Right Cessation
- 2001-12-17 NO NO20016149A patent/NO322313B1/no not_active IP Right Cessation
-
2002
- 2002-01-09 ZA ZA200200177A patent/ZA200200177B/en unknown
- 2002-11-19 HK HK02108380.9A patent/HK1048468B/zh not_active IP Right Cessation
-
2003
- 2003-02-20 HK HK03101303.7A patent/HK1049164A1/zh unknown
-
2004
- 2004-06-24 US US10/875,356 patent/US20040235930A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1212317T3 (da) | Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser | |
DK1021410T3 (da) | Prostaglandinagonister og deres anvendelse til behandling af knogletilstande | |
IS6385A (is) | Ný notkun og nýjar N-asabísýkló-amíð afleiður | |
NO20014560D0 (no) | Quinasoliner og terapautisk anvendelse derav | |
DK1459750T3 (da) | (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser | |
NO20021449D0 (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav | |
DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
NO20013393D0 (no) | Brönnsementeringsfremgangsmåter og sammensetninger | |
DK1286668T3 (da) | Farmaceutiske kombinationer indeholdende tegaserod og omeprazol og deres anvendelse til behandling af gastrointestinale sygdomme | |
IS6411A (is) | Kaspasa tálmar og notkun þeirra | |
NO20015362L (no) | Heterocyklisk substituerte benzimidazoler, deres fremstilling og anvendelse derav | |
DK1329456T3 (da) | Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme | |
NO20021379D0 (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
EE200100480A (et) | Ksenoon kasutamiseks närvimürgistuste ravis | |
NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
DK1392292T3 (da) | Pyranoindazoler og deres anvendelse til behandling af glaukom | |
NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
DK1432417T3 (da) | Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer | |
DK1106607T3 (da) | Uracilforbindelser og anvendelse deraf | |
DK1143997T3 (da) | Tumor nekrose faktor antagonister og deres anvendelse i behandling af endometriosis | |
NO986174D0 (no) | Triazinderivater og anvendelse derav | |
DK1341786T3 (da) | Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte | |
NO20020031D0 (no) | Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi | |
IS2607B (is) | Afleiður tryptamíns og hliðstæð efnasambönd ásamt lyfjaforskriftum þeirra |